Clin2
NCT07307534Possibly a fitNot yet recruiting

Nevus removal vs. no treatment for halo nevus with vitiligo

VitiligoHalo Nevus

Part of Cancer, Skin clinical trials.

This study compares surgically removing the central mole (nevus) versus leaving it alone in people who have both halo nevus and vitiligo. It aims to see which approach helps repigmentation better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
6 years to 45 years
Study type
Interventional

Who can take part

  • You have halo nevus (a mole with a white ring around it) along with non-segmental vitiligo
  • Your vitiligo covers 2% or less of your body surface, not counting hands and feet
  • You are between 6 and 45 years old
  • You are healthy enough to undergo minor surgery and local anesthesia
  • You have not used hormone medications, immune-modulating drugs, or light therapy in the past month
  • You are not pregnant or breastfeeding, and have no history of keloids or hypertrophic scarring

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07519031Not yet recruiting· Phase 1/Phase 2
Stem Cell Exosomes for Vitiligo Treatment

This study tests whether special particles derived from umbilical cord stem cells can help restore skin color in vitiligo (a condition causing loss of skin pigmentation). The treatment is being tested in adults with vitiligo affecting 1–30% of their body.

Xi'an, Shaanxi
NCT07472816Not yet recruiting· Phase 4
Mini-steroid pills to improve vitiligo surgery results

This trial tests whether taking small doses of steroids by mouth for a few days before and after a skin cell transplant (NCES) can reduce the white halo that sometimes forms around the treated area. It is for people with stable vitiligo on the face or trunk that hasn't responded to creams or light therapy.

Cairo
NCT07625891Recruiting· Phase 2
Testing D-2570 for non-segmental vitiligo

This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.

Shanghai, Shanghai Municipality
NCT06974669Not yet recruiting
Steroid pills and cell transplant for stable vitiligo

This trial tests whether adding short bursts of steroid pills to a skin cell transplant procedure can improve results for people with stable vitiligo on hard-to-treat areas like elbows and knees.

Giza
NCT06991972Recruiting· Phase 4
Needling vs. microneedling plus light therapy for vitiligo

This trial compares two types of needle treatments (needling and microneedling) combined with light therapy to see which works better for people with vitiligo that has lasted more than a year.

Peshawar, Khyber Pakhtunkhwa
NCT07398807Recruiting· Early Phase 1
Microneedling with chemo cream vs steroid cream for limited vitiligo

This study tests whether microneedling (tiny needles that prick the skin) combined with a chemotherapy cream (5-fluorouracil) works better than a strong steroid cream for treating vitiligo patches on a small area of the body. It's for people with limited vitiligo (covering no more than 10% of their body) who have not used other vitiligo treatments.

Chak Four Hundred Fifty-four

Hear when a new Vitiligo trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.